Methylation analysis by DNA immunoprecipitation (MeDIP)

Methods in Molecular Biology

Volumn 556, Issue , 2009, Pages 141-153

  Vucic, Emily A ^a   Wilson, Ian M ^a   Campbell, Jennifer M ^a   Lam, Wan L ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

array based methylation analysis; CpG islands; DNA methylation; epigenetic methods and technologies; Epigenetics; hypermethylation; hypomethylation; MeDIP aCGH; methylated DNA immunoprecipitation

Indexed keywords

DNA;

ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CPG ISLAND; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; HUMAN; IMMUNOPRECIPITATION; INSTRUMENTATION; METHODOLOGY; NEOPLASM; REPRODUCIBILITY;

COMPARATIVE GENOMIC HYBRIDIZATION; CPG ISLANDS; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; IMMUNOPRECIPITATION; NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 70349563392     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-192-9_10     Document Type: Article

References (21)

1. Esteller M, Herman JG. (2002) Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 196, 1-7.
2. Feinberg AP. (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447, 433-440.
3. Ozanne SE, Constancia M. (2007) Mechanisms of disease: The developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab. 3, 539-546.
4. Shames DS, Minna JD, Gazdar AF. (2007) DNA methylation in health, disease, and cancer. Curr Mol Med. 7, 85-102.
5. Jones PA, Baylin SB. (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet. 3, 415-428.
6. Feinberg AP, Ohlsson R, Henikoff S. (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet. 7, 21-33.
7. Glasspool RM, Teodoridis JM, Brown R. (2006) Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer. 94, 1087-1092.
8. Chekhun VF, Lukyanova NY, Kovalchuk O, Tryndyak VP, Pogribny IP. (2007) Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol Cancer Ther. 6, 1089-1098.
9. Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, et al. (2006) A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med. 3, e486.
10. Gryn J, Zeigler ZR, Shadduck RK, Lister J, Raymond JM, Sbeitan I, Srodes C, Meisner D, Evans C. (2002) Treatment of myelodysplastic syndromes with 5-azacytidine. Leuk Res. 26, 893-897.
11. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet. 37, 853-862.
12. Wilson IM, Davies JJ, Weber M, Brown CJ, Alvarez CE, MacAulay C, Schubeler D, Lam WL. (2006) Epigenomics: Mapping the methylome. Cell Cycle 5, 155-158.
13. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89, 1827-1831.
14. Gonzalgo ML, Liang G, Spruck CH, 3rd, Zingg JM, Rideout WM, 3rd, Jones PA. (1997) Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57, 594-599.
15. Huang TH, Laux DE, Hamlin BC, Tran P, Tran H, Lubahn DB. (1997) Identification of DNA methylation markers for human breast carcinomas using the methylationsensitive restriction fingerprinting technique. Cancer Res. 57, 1030-1034.
16. Livak KJ, Schmittgen TD. (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
17. Coe BP, Ylstra B, Carvalho B, Meijer GA, Macaulay C, Lam WL. (2007) Resolving the resolution of array CGH. Genomics 89, 647-653.
18. Khojasteh M, LamWL, Ward RK, MacAulay C. (2005) A stepwise framework for the normalization of array CGH data. BMC Bioinformatics 6, 274.
19. Branham WS, Melvin CD, Han T, Desai VG, Moland CL, Scully AT, Fuscoe JC. (2007) Elimination of laboratory ozone leads to a dramatic improvement in the reproducibility of microarray gene expression measurements. BMC Biotechnol. 7, 8.
20. Chi B, DeLeeuw RJ, Coe BP, MacAulay C, Lam WL. (2004) SeeGH - a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics. 5, 13.
21. Chari R, Lockwood WW, Coe BP, Chu A, MaceyD, Thomson A, Davies JJ,MacAulay C, Lam WL. (2006) SIGMA: A system for integrative genomic microarray analysis of cancer genomes. BMC Genomics 7, 324.